Publications by authors named "Barbara Denys"

Claim this Profile
T
The added value of automated HPC count: detecting clinically important interferences on the flow cytometric CD34+ cell count.
Alice Brochier, Mattias Hofmans, Stijn Lambrecht, Pauline Breughe, Barbara Denys

Clin Chem Lab Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze.
Lisa Proost, Stijn Lambrecht, Mattias Hofmans, Ciel De Vriendt, Marijn Speeckaert, Barbara Denys

Hemasphere· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature.
Philippe Decruyenaere, Dominiek Mazure, Ine Moors, Jo Van Dorpe, Malaïka Van der Linden, Barbara Denys

Acta Clin Belg· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.
Jesse M Tettero, Sylvie Freeman, Veit Buecklein, Adriano Venditti, Luca Maurillo, Barbara Denys

Hemasphere· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Michael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, Francesco Buccisano, Christopher S Hourigan, Barbara Denys

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm.
Sander De Bruyne, Eva Steel, Marjan Petrick, Barbara Denys, Karl Vandepoele

Clin Chem Lab Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach.
Barbara Depreter, Barbara De Moerloose, Karl Vandepoele, Anne Uyttebroeck, An Van Damme, Barbara Denys

Pediatr Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.
Barbara Depreter, Karin E Weening, Karl Vandepoele, Magnus Essand, Barbara De Moerloose, Barbara Denys

Haematologica· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Expression in Pediatric Acute Myeloid Leukemia.
Barbara Depreter, Barbara De Moerloose, Karl Vandepoele, Anne Uyttebroeck, An Van Damme, Barbara Denys

Hemasphere· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01.
Barbara De Moerloose, Ardine Reedijk, Geertruida H de Bock, Tim Lammens, Valerie de Haas, Barbara Denys

Pediatr Blood Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of measurable residual disease in AML: Review of current evidence.
Ine Moors, Karl Vandepoele, Jan Philippé, Dries Deeren, Dominik Selleslag, Barbara Denys

Crit Rev Oncol Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NF1 hotspot in acute myeloid leukemia: what's in a name?
Karl Vandepoele, Joni Van der Meulen, Barbara Denys

Leukemia· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients.
Diana Hanekamp, Barbara Denys, Gertjan J L Kaspers, Jeroen G Te Marvelde, Gerrit Jan Schuurhuis

Br J Haematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-related mRNA expression analysis using a novel flow cytometry-based assay.
Barbara Depreter, Jan Philippé, Magali Meul, Barbara Denys, Karl Vandepoele

Cytometry B Clin Cytom· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-based -ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML.
David G J Cucchi, Barbara Denys, Gertjan J L Kaspers, Jeroen J W M Janssen, Gert J Ossenkoppele

Blood· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The YPEL5-PPP1CB fusion transcript is detected in different hematological malignancies and in normal samples.
Karl Vandepoele, Jan Philippé, Barbara Denys

Leuk Res Rep· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis.
Eric Lippert, Olivier Mansier, Marina Migeon, Barbara Denys, Asa Nilsson

Haematologica· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.
Barbara Denys, Hakim El Housni, Friedel Nollet, Bruno Verhasselt, Jan Philippé

J Mol Diagn· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia: An update.
Barbara Denys, Katrien Devreese

Thromb Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia.
Barbara Denys, Veronique Stove, Jan Philippé, Katrien Devreese

Thromb Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poliovirus sampling by using sodium dodecyl sulfate/EDTA-pretreated chromatography paper strips.
Piet Maes, Els Van Doren, Barbara Denys, Inge Thoelen, Mustafizur Rahman

Biochem Biophys Res Commun· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis